Cas:1189467-93-3 2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol manufacturer & supplier

Chemical Name:2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol

CAS.NO:1189467-93-3

Synonyms:2,6-Bis[(H)-2-propanyl](O-H)phenol;Propofol-d18;2,6-Bis[(H)propan-2-yl](O-H)phenol;2,5-ANHYDRO-2,5-IMINO-D-MANNITOL HYDROCHLORIDE;Phenol-3,4,5-d-d, 2,6-bis[1-(methyl-d)ethyl-1,2,2,2-d]-

Molecular Formula:C₁₂D₁₈O

Molecular Weight:196.382

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:256.0±0.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.513

PSA:20.23000

Exact Mass:196.248749

LogP:4.16

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN1230 – class 3 – PG 2 – Meth

Packing Group:

Contact us for information like 2,6-Bis[(H)-2-propanyl](O-H)phenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenol-3,4,5-d-d, 2,6-bis[1-(methyl-d)ethyl-1,2,2,2-d]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-Bis[(H)propan-2-yl](O-H)phenol Use and application,2,6-Bis[(H)propan-2-yl](O-H)phenol technical grade,usp/ep/jp grade.

Related News: The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol manufacturer There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol supplier For example, an active ingredient to relieve pain is included in a painkiller. 2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol vendor There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol factory In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday.